Although the PD-1 blockade is more commonly known as an enhancer of effector T cells in tissues and the tumor microenvironment, it may also increase NK cell activity and antibody production through direct and indirect activation of PD-1+ B-cells 46. Here, PDCD1 is linked to neoplasm.